3-Bromo-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine

Catalog No. :
ACSLGM785
CAS No. :
1306829-95-7
Molecular Formula :
C6H5BrN4S
Molecular Weight :
245.10

IUPAC Name:3-bromo-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine

3-Bromo-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$55.00Login to see priceInquiryInquiry
1g95%$134.00Login to see priceIn stockInquiry
5g95%$537.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine
IUPAC Name3-bromo-6-(methylthio)-1H-pyrazolo[3,4-d]pyrimidine
MDL No.MFCD22415216
Molecular FormulaC6H5BrN4S
Molecular Weight245.10
SMILESCSC1=NC=C2C(NN=C2Br)=N1
InChI KeyPBEIXBIKEFRPGU-UHFFFAOYSA-N
Synonym1306829-95-7 | 3-BROMO-6-(METHYLTHIO)-1H-PYRAZOLO[3,4-D]PYRIMIDINE | 3-bromo-6-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidine | 3-bromo-6-methylsulfanyl-2H-pyrazolo[3,4-d]pyrimidine | 1H-Pyrazolo[3,4-d]pyrimidine, 3-bromo-6-(methylthio)- | MFCD22415216 | 3-BROMO-6-(ME
CAS No.1306829-95-7
PubChem CID53375434

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACSLGM785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIYEM751 route compound structure diagram
    ACIYEM751100047-42-5 In Stock
  2. Then
  3. ACSLGM785 route product structure diagram
    ACSLGM7851306829-95-7 In Stock
Inquiry

2. ACSLGM785 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIYEM751 route compound structure diagram
    ACIYEM751100047-42-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSLGM785 route product structure diagram
    ACSLGM7851306829-95-7 In Stock
Inquiry

Comments (0)